ACEIs |
angiotensin converting enzyme inhibitors |
Ang II |
angiotensin II |
AP-1 |
activating protein-1 |
ARBs |
angiotensin receptor blockers |
BCL6 |
B-cell lymphoma 6 |
CCBs |
calcium channel blockers |
CCL-2 |
C-C motif chemokine ligand 2 |
CVD |
cardiovascular disease |
DAMPs |
damage-associated molecular patterns |
EDGF |
endothelium-dependent vasoconstrictor factor |
eNOS |
endothelial nitric oxide synthase |
ET-1 |
endothelin-1 |
H2O2
|
hydrogen peroxide |
IL |
interleukin |
IFN-γ |
interferon gamma |
LDL |
low density lipoprotein |
M1 |
classic activated macrophages |
M2 |
alternatively activated macrophages |
MMF |
mycophenolate mofetil |
NADPH |
nicotinamide adenine dinucleotide phosphate |
NADPH-Ox |
nicotinamide adenine dinucleotide phosphate oxidase |
NFκB |
nuclear factor kappa-B |
NO |
nitric oxide |
PAMPs |
pathogen-associated molecular patterns |
PPRs |
pattern recognition receptors |
RAAS |
Activated renin-angiotensin-aldosterone system |
RAG1 |
recombination-activated gene 1 |
ROS |
reactive oxygen species |
Nrf2 |
nuclear E2-related factor 2 |
Th |
T helper |
TLR |
Toll-like receptors |
TNF-α |
tumor necrosis factor α |
TNFR |
TNF-α receptor |
Treg |
T regulatory cells |
VCDM |
vascular cell adhesion molecule |